PRO has been shown to inhibit growth, decrease vessel density and lower VEGF, MMP2/9 levels in neuroblastomas [59] and repress tumor growth in hemangiomas through hypoxia-inducible factor-1 alpha (HIF-1α) and STAT3 signaling [60]. This evidence concerns the gene HIF1A and neoplasm.